Equity grants to Progyny (PGNY) director Payson Norman detailed in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Progyny, Inc. director Payson Norman reported new equity awards and updated his holdings. On May 21, 2026, he received 5,660 restricted stock units, each representing one share of common stock. These RSUs vest on the earlier of May 21, 2027 or the day before the first annual shareholder meeting following the grant.
Norman was also granted stock options covering 27,119 shares of common stock at an exercise price of $24.69 per share, issued in lieu of a $39,990 cash retainer for board and committee service, plus an additional option for 3,203 shares at the same exercise price. These options vest on the same schedule as the RSUs.
After these awards, Norman directly holds 12,349 shares of Progyny common stock, along with the new options. Indirectly, 122,493 shares are held by The Norman C. and Melinda B. Payson Revocable Trust and 331,363 shares are held by EVO Eagle, LLC, where he shares voting and dispositive power.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Payson Norman
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,203 | $12.49 | $40K |
| Grant/Award | Stock Option (Right to Buy) | 27,119 | $0.00 | -- |
| Grant/Award | Common Stock | 5,660 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,203 shares (Direct, null);
Common Stock — 12,349 shares (Direct, null);
Common Stock — 331,363 shares (Indirect, See footnote)
Footnotes (1)
- Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities. The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
Key Figures
RSUs granted: 5,660 units
Stock options granted: 27,119 options
Additional stock options: 3,203 options
+5 more
8 metrics
RSUs granted
5,660 units
Restricted stock units granted on May 21, 2026
Stock options granted
27,119 options
Options on common stock granted in lieu of $39,990 cash retainer
Additional stock options
3,203 options
Separate option grant on common stock
Option exercise price
$24.69 per share
Exercise price for both new option grants
Direct common shares after grants
12,349 shares
Direct ownership following reported transactions
Indirect shares via Revocable Trust
122,493 shares
Held by The Norman C. and Melinda B. Payson Revocable Trust
Indirect shares via EVO Eagle, LLC
331,363 shares
Held by EVO Eagle, LLC with shared voting and dispositive power
Cash retainer replaced by options
$39,990
Board and committee cash retainer replaced with stock option grant
Key Terms
restricted stock units ("RSUs"), Revocable Trust, EVO Eagle, LLC, stock option, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Revocable Trust financial
"held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
EVO Eagle, LLC financial
"The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power"
stock option financial
"The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
voting and dispositive power financial
"The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities."
FAQ
What did Progyny (PGNY) director Payson Norman report in this Form 4?
Payson Norman reported new equity awards and updated holdings in Progyny (PGNY). He disclosed grants of restricted stock units and stock options, plus substantial indirect ownership through a family trust and an LLC, clarifying both his direct and indirect stake in the company’s common stock.
How many Progyny (PGNY) RSUs did Payson Norman receive on May 21, 2026?
He received 5,660 restricted stock units (RSUs) tied to Progyny common stock. Each RSU represents a contingent right to one share, vesting on May 21, 2027 or the day before the first annual shareholder meeting after the grant, assuming he continues board service.
What are the key terms of Payson Norman’s new Progyny (PGNY) stock options?
Norman was granted options for 27,119 shares at an exercise price of $24.69 per share, issued instead of a $39,990 cash retainer, plus another option for 3,203 shares at the same price. Both option grants vest on the same schedule as his RSUs.
When do Payson Norman’s new Progyny (PGNY) equity awards vest?
The RSUs and stock options vest on the earlier of May 21, 2027 or the calendar day immediately before Progyny’s first annual shareholder meeting following the grant date. Vesting is conditioned on Norman’s continued service with the company through that vesting date.
What indirect Progyny (PGNY) holdings did Payson Norman report?
Norman reported 122,493 shares of Progyny common stock held by The Norman C. and Melinda B. Payson Revocable Trust and 331,363 shares held by EVO Eagle, LLC. He serves as trustee for the trust and shares voting and dispositive power over the LLC-held shares.